The research institute will dedicate itself into developing technologies with sustained passion and a spirit of challenge to move forward to be a manufacturer of global raw pharmaceutical ingredients and intermediate products that are a key to medicine, which is the goal of PolarisAIPharma Co., Ltd.

We strive for R&D to survive infinite competition that only companies based on technical skill and quality can survive, and in the long term, we’ll concentrate the competence of research on the direction of developing optical active substances which are high-valued precise chemistry products requiring high technologies and high-degree complex technologies such as a separation technology etc. using chemical separation refinery technologies and enzyme that are secured up to now.

Simultaneously, we’ll introduce excellent basic technologies at home and abroad to develop new technologies and expand advancement to markets of developed countries such as Europe, Japan and the U.S. etc. that are very strict on the quality standard of medicine with an aim to be the leading company in the world competing and cooperating with companies in developed countries on the international stage by striving for commercialization of the topnotch technologies.